New England Research & Management, Inc. / GILD
New England Research & Management, Inc.’s Gilead Sciences Inc Position
Does New England Research & Management, Inc. own Gilead Sciences Inc (GILD)? Yes — 21.1K shares worth $3M (+1.04% of its 13F portfolio) as of Q2 2026, up from 11.1K shares the prior filed quarter.
Position Value
$3M
Q2 2026
Shares
21.1K
% of Portfolio
+1.04%
Quarters Held
14
currently held
Position History GILD
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q2 2026 | 21.1K | $3M | +1.04% |
| Q1 2026 | 11.1K | $2M | +0.65% |
| Q4 2025 | 11.7K | $1M | +0.63% |
| Q3 2024 | 4.8K | $402 | +0.19% |
| Q2 2024 | 5.4K | $370 | +0.18% |
| Q1 2024 | 16.8K | $1,232 | +0.60% |
| Q4 2023 | 5.5K | $448 | +0.24% |
| Q2 2022 | 12.3K | $763,000 | +0.44% |
| Q2 2020 | 5.4K | $416,000 | +0.30% |
| Q4 2019 | 20.5K | $1M | +0.89% |
| Q3 2019 | 9.4K | $595,000 | +0.43% |
| Q2 2019 | 9.4K | $637,000 | +0.43% |
| Q1 2019 | 9.9K | $644,000 | +0.44% |
| Q4 2018 | 10.4K | $648,000 | +0.51% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See New England Research & Management, Inc.’s full portfolio or all institutional holders of GILD.